Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Reporting (Tables)

v3.25.1
Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables present information about the Company’s reportable segment:
Year Ended December 31,
2024 2023
(in thousands)
Operating revenue $ 1,500,455  $ 1,266,375 
Less:
Medical claims expense (1,398,143) (1,117,258)
Other medical expense(1)
(161,229) (117,482)
Depreciation and amortization (86,058) (86,675)
Other segment items(2)
(140,532) (114,069)
Interest expense, net (22,173) (15,985)
Interest income 1,689  1,363 
Loss before income taxes (305,991) (183,731)
Income tax provision (4,387) (2,695)
Net loss $ (310,378) $ (186,426)
December 31,
2024 2023
(in thousands)
Segment assets $ 121,266  $ 118,497 
Other assets(3)
662,154  742,470 
Total assets $ 783,420  $ 860,967 
__________________
(1)Other medical expense includes subcapitation expense, affiliate provider compensation expense, and other non-claim costs.
(2)Other segment items include premium deficiency reserve, corporate, general and administrative expense, sales and marketing expense, impairment of asset held for sale, and miscellaneous income and expense.
(3)Other assets consists of cash, restricted cash, prepaid expenses and other current assets, other receivables, assets held for sale, and other long-term assets not allocated to the reportable segment.